- Investing.com
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Metrics to compare | A58 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipA58PeersSector | |
---|---|---|---|---|
P/E Ratio | 17.4x | 11.4x | −0.6x | |
PEG Ratio | 2.08 | 0.02 | 0.00 | |
Price/Book | 2.8x | 2.0x | 2.6x | |
Price / LTM Sales | 0.7x | 0.8x | 3.2x | |
Upside (Analyst Target) | - | −12.7% | 44.2% | |
Fair Value Upside | Unlock | −4.7% | 7.9% | Unlock |